Insider Trading activities of Xeris Pharmaceuticals Inc (XERS)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xeris Pharmaceuticals Inc (XERS) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Xeris Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Xeris Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is XERS. The reporting company's CIK number is 1346302.
The total value of stock buying since 2005 is $29,738,620.
The total value of stock sales since 2005 is $2,548,771.
The total value of stock option exercises since 2005 is $18,706.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Xeris Pharmaceuticals Inc (XERS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-04 0 $0 10,000 $95,650 0 $0
2019-03 30,000 $273,600 0 $0 0 $0
2019-02 596,500 $5,965,000 22,048 $331,695 0 $0
2019-01 0 $0 123,782 $1,872,689 0 $0
2018-12 0 $0 15,720 $248,737 15,720 $18,706
2018-06 1,566,668 $23,500,020 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Xeris Pharmaceuticals Inc insiders (XERS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-04-11 Prestrelski Steven (Chief Scientific Officer) Sale 10,000 9.56 95,650
2019-03-11 Edick Paul R (See Remarks) Buy 30,000 9.12 273,600
2019-02-19 Johnson Kenneth Erland (See Remarks) Buy 1,000 10.00 10,000
2019-02-19 Hecht Beth (See Remarks) Buy 2,500 10.00 25,000
2019-02-19 Green Jeremy Buy 588,000 10.00 5,880,000
2019-02-19 Deutsch Barry M. (See Remarks) Buy 5,000 10.00 50,000
2019-02-11 Deerfield Private Design Fund Iii, L.p. Sale 1,351 15.00 20,265
2019-02-08 Deerfield Private Design Fund Iii, L.p. Sale 5,890 15.11 88,986
2019-02-07 Deerfield Private Design Fund Iii, L.p. Sale 9,409 15.00 141,135
2019-02-06 Deerfield Private Design Fund Iii, L.p. Sale 400 15.00 6,000
2019-02-05 Deerfield Private Design Fund Iii, L.p. Sale 4,998 15.07 75,309
2019-01-29 Deerfield Private Design Fund Iii, L.p. Sale 6,210 15.14 94,025
2019-01-28 Deerfield Private Design Fund Iii, L.p. Sale 828 15.00 12,420
2019-01-25 Deerfield Private Design Fund Iii, L.p. Sale 76,820 15.08 1,158,291
2019-01-24 Deerfield Private Design Fund Iii, L.p. Sale 5,425 15.04 81,564
2019-01-23 Deerfield Private Design Fund Iii, L.p. Sale 32,199 16.35 526,389
2019-01-11 Prestrelski Steven (Chief Scientific Officer) Sale 2,300 .00 0
2018-12-26 Prestrelski Steven (Chief Scientific Officer) Sale 15,720 15.82 248,737
2018-12-24 Prestrelski Steven (Chief Scientific Officer) Option Ex 15,720 1.19 18,706
2018-06-25 Palmetto Partners 2015, Lp (10% Owner) Buy 150,000 15.00 2,250,000
2018-06-25 Green Jeremy Buy 666,668 15.00 10,000,020
2018-06-25 Deerfield Private Design Fund Iii, L.p. Buy 750,000 15.00 11,250,000

Insider trading activities including stock purchases, stock sales, and option exercises of XERS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Xeris Pharmaceuticals Inc (symbol XERS, CIK number 1346302) see the Securities and Exchange Commission (SEC) website.